Published in J Exp Med on April 30, 1930
I. THE PERMEABILITY OF THE WALL OF THE LYMPHATIC CAPILLARY. J Exp Med (1932) 4.95
THE LYMPHATIC PARTICIPATION IN HUMAN CUTANEOUS PHENOMENA : A STUDY OF THE MINUTE LYMPHATICS OF THE LIVING SKIN. J Exp Med (1933) 4.51
THE VESSELS INVOLVED IN HYDROSTATIC TRANSUDATION. J Exp Med (1932) 4.25
THE GRADIENT OF VASCULAR PERMEABILITY : II. THE CONDITIONS IN FROG AND CHICKEN MUSCLE, AND IN THE MAMMALIAN DIAPHRAGM. J Exp Med (1931) 4.20
THE GRADIENT OF VASCULAR PERMEABILITY : IV. THE PERMEABILITY OF THE CUTANEOUS VENULES AND ITS FUNCTIONAL SIGNIFICANCE. J Exp Med (1931) 4.19
THE GRADIENT OF PERMEABILITY OF THE SKIN VESSELS AS INFLUENCED BY HEAT, COLD, AND LIGHT. J Exp Med (1932) 4.15
THE GRADIENT OF VASCULAR PERMEABILITY : III. THE GRADIENT ALONG THE CAPILLARIES AND VENULES OF FROG SKIN. J Exp Med (1931) 4.07
THE RELATION OF HYDROSTATIC PRESSURE TO THE GRADIENT OF CAPILLARY PERMEABILITY. J Exp Med (1932) 2.95
A concurrent flow model for extraction during transcapillary passage. Circ Res (1974) 2.64
PHYSIOLOGICAL CONDITIONS EXISTING IN CONNECTIVE TISSUE : I. TTHE METHOD OF INTERSTITIAL SPREAD OF VITAL DYES. J Exp Med (1939) 1.27
THE PHENOMENON OF LOCAL SKIN REACTIVITY TO BACTERIAL FILTRATES: ELICITATION OF LOCAL REACTIVITY BY WAY OF THE VASCULAR SYSTEM. J Exp Med (1935) 1.08
Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol (2013) 0.99
Early adaptive responses of the vascular wall during venous arterialization in mice. Am J Pathol (2004) 0.98
Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability. Am J Physiol Heart Circ Physiol (2006) 0.85
THE INFLUENCE OF THE PLASMA COLLOIDS ON THE GRADIENT OF CAPILLARY PERMEABILITY. J Exp Med (1932) 0.80
Human detectability of various modulation wave forms in frequency-modulated tones [proceedings]. J Physiol (1978) 0.75
[On the problems of the existence of a gradient of vascular permeability at the terminal vascular system]. Arch Kreislaufforsch (1969) 0.75
The Distribution and Movement of Water and Solutes in the Human Body. Yale J Biol Med (1933) 0.75
RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION. J Exp Med (1920) 10.36
STUDIES OF TISSUE MAINTENANCE : I. THE CHANGES WITH DIMINISHED BLOOD BULK. J Exp Med (1929) 5.42
OUTLYING ACIDOSIS DUE TO FUNCTIONAL ISCHEMIA. J Exp Med (1929) 4.21
THE LIVER REQUIREMENT OF THE FASTING ORGANISM. J Exp Med (1924) 2.54
STUDIES OF TISSUE MAINTENANCE : II. THE SERVICE TO THE LIVER AND DIGESTIVE TRACT AFTER HEMORRHAGE. J Exp Med (1929) 1.93
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : IV. INDICATED DIFFERENCES IN THE REACTION OF THE ORGANS ON VITAL STAINING WITH PHTHALEINS. J Exp Med (1925) 21.41
THE PROTECTION OF PATHOGENIC MICROORGANISMS BY LIVING TISSUE CELLS. J Exp Med (1916) 18.60
THE PRESERVATION OF LIVING RED BLOOD CELLS IN VITRO : I. METHODS OF PRESERVATION. J Exp Med (1916) 16.74
THE CONCENTRATING ACTIVITY OF THE GALL BLADDER. J Exp Med (1921) 15.25
THE INFLUENCE OF DIET ON TRANSPLANTED AND SPONTANEOUS MOUSE TUMORS. J Exp Med (1914) 14.24
A METHOD FOR OBTAINING SUSPENSIONS OF LIVING CELLS FROM THE FIXED TISSUES, AND FOR THE PLATING OUT OF INDIVIDUAL CELLS. J Exp Med (1916) 12.14
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN-TISSUES : II. ON THE MOBILIZATION OF ACID MATERIAL WITHIN CELLS, AND THE REACTION AS INFLUENCED BY THE CELL STATE. J Exp Med (1925) 11.41
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : I. GENERAL FEATURES OF VITAL STAINING WITH LITMUS. J Exp Med (1925) 10.98
RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION. J Exp Med (1920) 10.36
THE NORMAL FATE OF ERYTHROCYTES : I. THE FINDINGS IN HEALTHY ANIMALS. J Exp Med (1917) 10.08
THE PROGRESSION TO CARCINOMA OF VIRUS-INDUCED RABBIT PAPILLOMAS (SHOPE). J Exp Med (1935) 7.99
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : III. INDICATED DIFFERENCES IN THE REACTION OF THE BLOOD AND TISSUES ON VITAL STAINING WITH PHTHALEINS. J Exp Med (1925) 6.15
A METHOD FOR THE PERMANENT STERILE DRAINAGE OF INTRAABDOMINAL DUCTS, AS APPLIED TO THE COMMON DUCT. J Exp Med (1923) 6.03
THE FIXATION AND PROTECTION OF VIRUSES BY THE CELLS OF SUSCEPTIBLE ANIMALS. J Exp Med (1935) 5.95
STUDIES OF TISSUE MAINTENANCE : I. THE CHANGES WITH DIMINISHED BLOOD BULK. J Exp Med (1929) 5.42
CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES : A STUDY OF THE TAR TUMORS OF RABBITS. J Exp Med (1941) 4.54
A VIRUS-INDUCED MAMMALIAN GROWTH WITH THE CHARACTERS OF A TUMOR (THE SHOPE RABBIT PAPILLOMA) : I. THE GROWTH ON IMPLANTATION WITHIN FAVORABLE HOSTS. J Exp Med (1934) 4.32
OUTLYING ACIDOSIS DUE TO FUNCTIONAL ISCHEMIA. J Exp Med (1929) 4.21
THE GRADIENT OF VASCULAR PERMEABILITY : III. THE GRADIENT ALONG THE CAPILLARIES AND VENULES OF FROG SKIN. J Exp Med (1931) 4.07
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : VI. FACTORS DETERMINING THE REACTION OF SKIN GRAFTS; A STUDY BY THE INDICATOR METHOD OF CONDITIONS WITHIN AN ISCHEMIC TISSUE. J Exp Med (1926) 3.93
THE BILIARY FACTOR IN LIVER LESIONS. J Exp Med (1920) 3.71
PHYSIOLOGICAL CAUSES FOR THE VARIED CHARACTER OF STASIS BILE. J Exp Med (1921) 3.70
OBSERVATIONS ON THE RELATION OF THE VIRUS CAUSING RABBIT PAPILLOMAS TO THE CANCERS DERIVING THEREFROM : II. THE EVIDENCE PROVIDED BY THE TUMORS: GENERAL CONSIDERATIONS. J Exp Med (1936) 3.55
The course of the vaso-constrictor nerves to the periphery. J Physiol (1932) 3.46
A COMPARISON OF VIRUS-INDUCED RABBIT TUMORS WITH THE TUMORS OF UNKNOWN CAUSE ELICITED BY TARRING. J Exp Med (1939) 3.33
Cerebral perfusion deficits in dysbaric illness. Lancet (1989) 3.31
A VIRUS-INDUCED MAMMALIAN GROWTH WITH THE CHARACTERS OF A TUMOR (THE SHOPE RABBIT PAPILLOMA) : III. FURTHER CHARACTERS OF THE GROWTH: GENERAL DISCUSSION. J Exp Med (1934) 3.12
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med (1993) 2.76
STUDIES ON THE TOTAL BILE : II. THE RELATION OF CARBOHYDRATES TO THE OUTPUT OF BILE PIGMENT. J Exp Med (1923) 2.71
ON IMMUNITY TO TRANSPLANTABLE CHICKEN TUMORS. J Exp Med (1914) 2.63
THE ACTIVATING, TRANSFORMING, AND CARCINOGENIC EFFECTS OF THE RABBIT PAPILLOMA VIRUS (SHOPE) UPON IMPLANTED TAR TUMORS. J Exp Med (1940) 2.59
THE LIVER REQUIREMENT OF THE FASTING ORGANISM. J Exp Med (1924) 2.54
OBSERVATIONS ON SOME CAUSES OF GALL STONE FORMATION : I. EXPERIMENTAL CHOLELITHIASIS IN THE ABSENCE OF STASIS, INFECTION, AND GALL BLADDER INFLUENCES. J Exp Med (1924) 2.53
The Mosoriot medical record system: design and initial implementation of an outpatient electronic record system in rural Kenya. Int J Med Inform (2000) 2.52
Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J (1968) 2.52
Purification of an exo-beta-D-(1 bonded to 3)-glucanase from Basidiomycete species QM 806. J Biol Chem (1968) 2.30
Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J (1997) 2.28
THE CARCINOGENIC EFFECT OF A PAPILLOMA VIRUS ON THE TARRED SKIN OF RABBITS : I. DESCRIPTION OF THE PHENOMENON. J Exp Med (1938) 2.24
FREE ANTIGEN AND ANTIBODY CIRCULATING TOGETHER IN LARGE AMOUNTS (HEMAGGLUTININ AND AGGLUTINOGEN IN THE BLOOD OF TRANSFUSED RABBITS). J Exp Med (1918) 2.15
OBSERVATIONS ON SOME CAUSES OF GALL STONE FORMATION : II. ON CERTAIN SPECIAL NUCLEI OF DEPOSITION IN EXPERIMENTAL CHOLELITHIASIS. J Exp Med (1924) 2.13
Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology (1996) 2.13
Innovative method for carbon dioxide determination in human postmortem cardiac gas samples using headspace-gas chromatography-mass spectrometry and stable labeled isotope as internal standard. Anal Chim Acta (2013) 2.06
Nasal Medication in Sinusitis. Can Med Assoc J (1945) 2.01
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med (1980) 1.95
EXPERIMENTAL HEMOCHROMATOSIS. J Exp Med (1918) 1.94
Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiol (2001) 1.93
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : VII. THE INFLUENCE OF CHANGES IN THE REACTION OF THE BLOOD UPON THE REACTION OF THE TISSUES. J Exp Med (1926) 1.86
Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol (1998) 1.84
THE NEOPLASTIC POTENTIALITIES OF MOUSE EMBRYO TISSUES : I. THE FINDINGS WITH SKIN OF C STRAIN EMBRYOS TRANSPLANTED TO ADULT ANIMALS. J Exp Med (1945) 1.78
Changes occurring in plasma and serum on storage and their physiological effects. J Physiol (1944) 1.74
SELECTION WITH THE MAGNET AND CULTIVATION OF RETICULO-ENDOTHELIAL CELLS (KUPFFER CELLS). J Exp Med (1934) 1.70
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis (1999) 1.64
Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther (2009) 1.63
Reduced cardiac selenium content in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr (1990) 1.59
THE FINAL RESPONSE OF THE SMALL CUTANEOUS VESSELS. J Exp Med (1929) 1.58
The fate of carotene introduced into the circulation. J Physiol (1934) 1.56
An integrated assessment framework for climate change and infectious diseases. Environ Health Perspect (1999) 1.54
Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. JAMA (1967) 1.54
Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol (1995) 1.48
THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : VIII. ON THE COURSE OF THE TISSUE ACIDOSIS SECONDARY TO BLOOD ACIDOSIS INDUCED WITH HYDROCHLORIC ACID. J Exp Med (1927) 1.48
Why fisheries collapse and what to do about it. Proc Natl Acad Sci U S A (1996) 1.47
EXPERIMENTS ON THE PRODUCTION OF SPECIFIC ANTISERA FOR INFECTIONS OF UNKNOWN CAUSE : II. THE PRODUCTION OF A SERUM EFFECTIVE AGAINST THE AGENT CAUSING A CHICKEN SARCOMA. J Exp Med (1919) 1.46
URINARY SIDEROSIS : HEMOSIDERIN GRANULES IN THE URINE AS AN AID IN THE DIAGNOSIS OF PERNICIOUS ANEMIA, HEMOCHROMATOSIS, AND OTHER DISEASES CAUSING SIDEROSIS OF THE KIDNEY. J Exp Med (1918) 1.42
Personality as a vulnerability factor to depression. Br J Psychiatry (1991) 1.41
Acute pericarditis with effusion and the general surgeon. Trop Doct (1989) 1.39
Exercise prescription in primary care. Br J Gen Pract (1997) 1.38
Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia. J Pediatr (1992) 1.28
METHOD FOR INTRAVENOUS INJECTION OF GUINEA PIGS. J Exp Med (1918) 1.28
EXPERIMENTS ON THE PRODUCTION OF SPECIFIC ANTISERA FOR INFECTIONS OF UNKNOWN CAUSE : III. THE EFFECTS OF A SERUM PRECIPITIN ON ANIMALS OF THE SPECIES FURNISHING THE PRECIPITINOGEN. J Exp Med (1920) 1.28
The type II epithelial cells of the lung. II. Chemical composition and phospholipid synthesis. Lab Invest (1975) 1.25
A potential mechanism for age-related declines in patellar tendon biomechanics. J Orthop Res (2002) 1.21
Availability and choice of antimalarials at medicine outlets in Ghana: the question of access to effective medicines for malaria control. Clin Pharmacol Ther (2008) 1.15
Spontaneous rectus sheath haematoma mimicking an enlarged urinary bladder. Hosp Med (2000) 1.15
Can patients' preferences for involvement in decision-making regarding the use of medicines be predicted? Patient Educ Couns (2007) 1.15
Unilateral renal vein thrombosis and the nephrotic syndrome. Pediatrics (1972) 1.13
THE EFFECT OF CHEMICAL CARCINOGENS ON VIRUS-INDUCED RABBIT PAPILLOMAS. J Exp Med (1944) 1.11
Immunosuppressive therapy of proliferative glomerulonephritis in children. Am J Dis Child (1969) 1.10
Paraplegia following intrathecal chemotherapy. Cancer (1972) 1.09
The vagaries of self-reports of physical activity: a problem revisited and addressed in a study of exercise promotion in the over 65s in general practice. Fam Pract (1999) 1.06
ANTIBIOTICS. Can Med Assoc J (1946) 1.06
Attention and working memory in resident anaesthetists after night duty: group and individual effects. Occup Environ Med (2004) 1.04
Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr (1985) 1.02
Mailed reminders for area-wide influenza immunization: a randomized controlled trial. J Am Geriatr Soc (1999) 1.02
Implementation of a pneumatic-tube system for transport of blood specimens. Am J Clin Pathol (1978) 1.02
A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis (1981) 1.01
A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol (1982) 1.01
Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum (1997) 1.00
Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma (2001) 0.99
Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects. J Periodontol (1995) 0.99
Substrate specificity of mycodextranase. Nature (1966) 0.98
Direct peptide profiling by mass spectrometry of single identified neurons reveals complex neuropeptide-processing pattern. J Biol Chem (1994) 0.98
The MOSORIOT medical record system (MMRS) phase I to phase II implementation: an outpatient computer-based medical record system in rural Kenya. Stud Health Technol Inform (2001) 0.98
Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J Infect Dis (1979) 0.97
Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J Rheumatol (1996) 0.96